Compliance Risk Solutions
Bringing decades of practical in-house, business oriented compliance solutions to your company


Industry Groups Applaud House Passage of FDARA

BIO and PhRMA issued statements expressing the groups’ approval of the continuation of user fee programs. Jul 13, 2017 By Pha …

July 14, 2017

FDA deal would relax rules on reporting medical device problems

Reposted from The New York Times Sheila Kaplan Wednesday, 12 Jul 2017 | 11:37 AM Makers of cardiac defibrillators, insulin pu …

July 13, 2017